May 5, 2018
A Call for a Better Solution for Women
A recent JAMA Surgery article "Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation" in the April 11, 2018 issue highlights the ongoing challenge we are trying to solve.
The study looked at over 75,000 patients undergoing hysterectomy from over 600 US hospitals to assess changes in the rates of 30-day major and minor complications for benign gynecologic indications following the the black box warning by the FDA in 2014. The study found that in women undergoing hysterectomy for uterine fibroids (33.9% of patients) more received open hysterectomies and had a corresponding increase in complication rates. The authors concluded that "the 20% increase in the odds of major and minor complications could translate into a large number of additional complications among the 200,000 hysterectomies performed annually for uterine fibroids in the United States."
This means that more women annually in the U.S. undergoing hysterectomy for benign indications will experience a major complication such as sepsis, pneumonia, deep incisional surgical site infection, acute renal failure, pulmonary embolism, cardiac arrest requiring cardiopulmonary resuscitation, and stroke or cerebrovascular accident with neurological deficit.
The benefits of minimally invasive surgery are well known, and this study highlights our mission to answer the call for a better solution for women.
Posted by Kristin Johnson, CEO and Co-Founder